ScPharmaceuticals raises $90M in IPO with heart failure drug on deck
ScPharmaceuticals, a company with a heart failure drug on deck for FDA approval, raised about $90 million in an IPO Friday, coming in at the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
